Treatment of relapsed/refractory CLL with Venetoclax-Rituximab during the COVID-19 pandemic: A daily-life experience in southern Italy. (2021). Mediterranean Journal of Hematology and Infectious Diseases, 13(1), e2021042. https://doi.org/10.4084/MJHID.2021.042